ALLISON PUSEY: Open Payments
NPI 1366163172 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 43 payments from 13 companies in 2025. Trend: 2023 $1,031 · 2024 $1,292 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $216 |
| Corcept Therapeutics | 7 | $212 |
| Novo Nordisk Inc | 9 | $161 |
| Lilly USA, LLC | 6 | $107 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Exact Sciences Corporation | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $24 |
Products named: Korlym, EVENITY, Wegovy, MOUNJARO, VOQUEZNA, TZIELD, Cologuard Collection Kit, XIFAXAN.
Industry payments across MD — which companies pay providers there.
